Spinal Implants | Medtech 360 | Market Insights | Asia Pacific | 2019
本報告提供亞太地區各國的脊椎移植的市場相關分析，) ，及各產品類型 (胸腰椎移植，傳統頸部植入，椎間融合設備，脊椎非固定技術)的詳細趨勢整體市場趨勢預測 (今後10年份，市場競爭狀況 (主要企業的市場佔有率等)，主要的推動及阻礙市場要素等的相關調查。
Favorable demographics and increased access to health care in some of the countries covered will support procedure volume expansion, driving growth in the Asia Pacific spinal implant market through 2027. Although the spinal implant market will be somewhat limited by pricing pressures, challenging reimbursement environments, and nationalist policies in China and India, advancements in medical facilities, and an increased focus on physician training will lead to overall spinal implant market growth.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for spinal implants in the Asia Pacific region across a 10-year period.
How will reforms such as the Ayushman Bharat Yojana impact the Indian spinal implant market?
How will such reforms affect adoption of MNC and domestic manufacturer products?
How will government initiatives, such as China's two-invoice policy, affect the growth potential of this market?
As the largest market in the Asia Pacific region, to what extent will procedure volumes grow within the Chinese market for spinal implants?
How will the Indian market grow in comparison to China and the rest of the Asia Pacific region?
How will the South Korean and Australian markets grow, and how will they compare to the emerging Chinese and Indian markets?
How will the dominance of foreign MNCs in Australia affect ASPs and market growth through 2027?
How will increased scrutiny over reimbursement affect these markets through the forecast period?
What are the key competitive strategies that foreign MNCs and local companies must be mindful of?
Which local competitors have been able to capture notable shares within the Asia Pacific spinal implant space?
How will purchasing priorities in this region evolve through the forecast period?
Diwakar Bahuguna is a research associate within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Decision Resources Group, specializing in hyaluronic acid viscosupplementation and Latin American aesthetic injectables markets. Diwakar holds a Bachelor's degree in Pharmacy from the University of Delhi and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Mohali.